Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose

Acta Diabetologica

Volumn 48, Issue 3, 2011, Pages 209-217

  Kanat, Mustafa ^a   Norton, Luke ^a   Winnier, Diedre ^a   Jenkinson, Chris ^a   Defronzo, Ralph A ^a   Abdul Ghani, Muhammad A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance; Insulin secretion

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DENATURATION;

ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; PREDIABETIC STATE; TIME FACTORS;

EID: 80052388638     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0285-x     Document Type: Article

References (45)

1. WHO Study Group (1985) Diabetes mellitus. Technical report Series 727. World Health Organization, Geneva
2. The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1183 1197
3. N Unwin J Shaw P Zimmet KGMM Alberti 2002 Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention Diabet Med 19 708 723 12207806 10.1046/j.1464-5491.2002.00835.x 1:STN:280:DC%2BD38vltlaluw%3D%3D (Pubitemid 35013848)
4. F de Vegt JM Dekker CD Stehouwer G Nijpels LM Bouter RJ Heine 1998 The 1997 American diabetes association criteria versus the 1985 world health organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study Diabetes Care 21 1686 1690 9773731 10.2337/diacare.21.10.1686 (Pubitemid 28449808)
5. D Dunstan P Zimmet T Welborn M de Courten A Cameron R Sicree, et al. 2002 The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study Diabetes Care 25 829 834 11978676 10.2337/diacare.25.5.829 (Pubitemid 41094278)
6. H Larsson G Berglund F Lindgarde B Ahren 1998 Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance Diabetologia 41 1124 1125 9754834 10.1007/s001250050986 1:STN:280:DyaK1cvisFyhuw%3D%3D (Pubitemid 28313709)
7. MI Harris RC Eastman CC Cowie KM Flegal MS Eberhardt 1997 Comparison of diabetes diagnostic categories in the US population according to the 1997 American Diabetes Association and 1980-85 World Health Organization diagnostic criteria Diabetes Care 20 1859 1862 9405907 10.2337/diacare.20.12.1859 1:STN:280:DyaK1c%2FmvV2rsw%3D%3D (Pubitemid 27522896)
8. GT Ko JC Chan J Woo CS Cockram 1998 Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population Diabetes Care 21 2094 2097 9839099 10.2337/diacare.21.12.2094 1:STN:280:DyaK1M%2Fls1Ckug%3D%3D (Pubitemid 28549156)
9. The DECODE Study Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria Lancet 354 617 621 10.1016/S0140-6736(98)12131-1 (Pubitemid 29391424)
10. C Weyer C Bogardus DM Mott RE Pratley 1999 The natural history of insulin secretory disfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J Clin Invest 104 787 794 10491414 10.1172/JCI7231 1:CAS:528:DyaK1MXmtFGltbg%3D (Pubitemid 29536364)
11. E Ferrannini A Gastaldelli Y Miyazaki M Matsuda M Pettiti A Mari, et al. 2003 Predominant role of reduced beta-cell sensitivity to glucose over insulin sensitivity in impaired glucose tolerance Diabetologia 46 1211 1219 12879253 10.1007/s00125-003-1169-6 1:CAS:528:DC%2BD3sXmvFCitbc%3D (Pubitemid 37214979)
12. WP Pimenta ML Santos NS Cruz FF Aragon CR Padovani JE Gerich 2002 Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion Diabetes Metab 28 468 476 12522327 1:CAS:528:DC%2BD3sXhs12jtbY%3D (Pubitemid 36077149)
13. A Gastaldelli E Ferrannini Y Miyazaki M Matsuda RA DeFronzo San Antonio metabolism study 2004 Beta-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study Diabetologia 47 31 39 14666364 10.1007/s00125-003-1263-9 1:CAS:528:DC%2BD2cXjsFeqsg%3D%3D (Pubitemid 38141937)
14. TWV Haeften W Pimenta A Mitrakou M Korytkowski T Jenssen H Yki-Jarvinen, et al. 2002 Disturbance in beta cell function in impaired fasting glycemia Diabetes 51 Suppl 1 S265 S270 11815491 10.2337/diabetes.51.2007.S265
15. A Festa R D'Agostino A Hanley AJ Karter MF Saad SM Haffner 2004 Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose Diabetes 53 1549 1555 15161760 10.2337/diabetes.53.6.1549 1:CAS:528:DC%2BD2cXkslCgs7c%3D (Pubitemid 38697668)
16. C Weyer C Bogardus R Pratley 1999 Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance Diabetes 48 2197 2203 10535454 10.2337/diabetes.48.11.2197 1:CAS:528: DyaK1MXntVSlsLs%3D (Pubitemid 29521850)
17. D Tripathy M Carlsson P Almgren B Isomaa MR Taskinen T Tuomi, et al. 2000 Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study Diabetes 49 975 980 10866050 10.2337/diabetes.49. 6.975 1:CAS:528:DC%2BD3cXjvFylurc%3D (Pubitemid 30349420)
18. F Guerrero-Romero M Rodriguez-Moran 2001 Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose J Diabetes Complicat 5 34 37 10.1016/S1056-8727(00)00131-8 (Pubitemid 32203889)
19. ME Piche JP Despres A Pascot A Nadeau A Tremblay SJ Weisnagel, et al. 2004 Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk? Diabet Med 21 730 737 15209766 10.1111/j.1464-5491.2004.01234.x 1:CAS:528:DC%2BD2cXmsVKqsLw%3D (Pubitemid 38916218)
20. C Snehalatha A Ramachandran S Sivasankari K Satyavani V Vijay 2003 Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians Diabetes Metab Res Rev 9 329 332 10.1002/dmrr.388 (Pubitemid 36939859)
21. M Hanefeld C Koehler K Fuecker E Henkel F Schaper T Temelkova-Kurktschiev 2003 Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose, the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study Diabetes Care 26 868 874 12610051 10.2337/diacare.26.3.868 1:CAS:528:DC%2BD3sXisVCltLg%3D (Pubitemid 36929357)
22. MA Abdul-Ghani C Jenkinson D Richardson D Tripathy RA DeFronzo 2006 Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VEGAS) Diabetes 55 1430 1435 16644701 10.2337/db05-1200 1:CAS:528:DC%2BD28XksFahtb0%3D (Pubitemid 44195383)
23. SD Mittelman GW Van Citters SP Kim DA Davis MK Dea M Hamilton-Wessler, et al. 2000 Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response Diabetes 49 2116 2125 11118015 10.2337/diabetes.49.12.2116 1:CAS:528:DC%2BD3cXos1ejsL8%3D
24. H Yoshii TKT Lam N Gupta T Goh CA Haber H Uchino, et al. 2006 Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux Am J Physiol 290 E1089 E1097 1:CAS:528:DC%2BD28XlvVejtbc%3D
25. MB Davidson MD Harris CS Rosenberg 1987 Inverse relationship of metabolic clearance rate of insulin to body mass index Metabolism 36 219 222 3547012 10.1016/0026-0495(87)90179-X 1:CAS:528:DyaL2sXnvFWgug%3D%3D (Pubitemid 17047356)
26. AN Peiris RA Mueller GA Smith MF Struve AH Kissebah 1986 Splanchnic insulin metabolism in obesity. Influence of body fat distribution J Clin Invest 78 1648 1657 3537010 10.1172/JCI112758 1:CAS:528:DyaL2sXjtVykug%3D%3D (Pubitemid 17219529)
27. F Cerutti C Sacchetti A Bessone I Rabbone P Cavallo-Perin G Pacini 1998 Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescent Acta Paediatr 87 1045 1050 9825970 10.1111/j.1651-2227.1998.tb01411.x 1:STN:280: DyaK1M%2FktFensQ%3D%3D (Pubitemid 28476000)
28. RN Bergman N Ader K Huecking G Van Citers 2002 Accurate assessment of beta cell function: the hyperbolic corrections Diabetes 51 Suppl 1 S212 S220 11815482 10.2337/diabetes.51.2007.S212 1:CAS:528:DC%2BD38XhtVaqsbs%3D
29. RA DeFronzo J Tobin R Andres 1979 Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance Am J Physiol 237 E214 E223 382871 1:CAS:528:DyaE1MXlslWhs70%3D
30. MA Abdul-Ghani M Matsuda C Jenkinson D Richardson K Kaku RA DeFronzo 2008 The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance Am J Physiol 295 2 E401 E406 1:CAS:528:DC%2BD1cXhtVaktrvM
31. M Matsuda RA DeFronzo 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic glucose clamp Diabetes Care 22 1462 1470 10480510 10.2337/diacare.22.9.1462 1:STN:280:DyaK1MvgvVertQ%3D%3D (Pubitemid 29418240)
32. R Retnakaran S Shen AJ Hanley V Vuksan JK Hamilton B Zinman 2008 Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test Obesity 16 1901 1907 18551118 10.1038/oby.2008.307 1:CAS:528:DC%2BD1cXptFOrtLs%3D
33. IF Godsland JA Jeffs DG Johnston 2004 Loss of beta cell function as fasting glucose increases in the non-diabetic range Diabetologia 47 1157 1166 15249997 10.1007/s00125-004-1454-z 1:CAS:528:DC%2BD2cXmt1KktLs%3D (Pubitemid 39093312)
34. L Luzi RA DeFronzo 1989 Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans Am J Physiol 257 E241 E246 2669517 1:CAS:528:DyaL1MXlt1Onsbw%3D
35. J Meyer J Sturis M Katschinski R Arnold B Goke MM Byrne 2002 Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose Am J Physiol Endocrinol Metab 282 E917 E922 11882513 1:CAS:528:DC%2BD38XivVels7s%3D
36. L Rossetti GI Shulman W Zawalich RA DeFronzo 1987 Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats J Clin Invest 80 1037 1044 3308956 10.1172/JCI113157 1:CAS:528:DyaL2sXmtlCiurY%3D (Pubitemid 18075639)
37. JL Leahy S Bonner-Weir GC Weir 1988 Minimal chronic hyperglycemia is a determinant of impaired insulin secretion after an incomplete pancreatectomy J Clin Invest 81 1407 1414 3284912 10.1172/JCI113470 1:CAS:528:DyaL1cXkt1Wis7k%3D
38. ML Hribal L Perego S Lovari F Andreozzi R Menghini C Perego G Finzi L Usellini C Placidi C Capella V Guzzi D Lauro F Bertuzzi A Davalli G Pozza A Pontiroli M Federici R Lauro A Brunetti F Folli G Sesti 2003 Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans FASEB J. 17 1340 1342 12738810 1:CAS:528:DC%2BD3sXltFertLc%3D
39. LK Olson JB Redmon HC Towle RP Robertson 1993 Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription, alters binding of insulin gene regulatory protein J Clin Invest 92 514 519 8326016 10.1172/JCI116596 1:CAS:528:DyaK3sXlslyltr0%3D (Pubitemid 23209037)
40. L Rossetti A Giaccari 1990 DeFronzo RA Glucose toxicity Diabetes Care 13 610 630 2192847 10.2337/diacare.13.6.610 1:STN:280:DyaK3c3ptFyksw%3D%3D
41. WT Garvey JM Olefsky J Griffin RF Hamman OG Kolterman 1985 The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus Diabetes 34 222 234 3882489 10.2337/diabetes.34.3.222 1:STN:280:DyaL2M7ivVSnsg%3D%3D (Pubitemid 15134779)
42. SM Ruchat CE Elks RJ Loos MC Vohl SJ Weisnagel T Rankinen C Bouchard L Pérusse 2009 Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies Acta Diabetol 46 217 226 19082521 10.1007/s00592-008-0080-5 1:CAS:528:DC%2BD1MXptVGmsrk%3D
43. E Resmini F Minuto A Colao D Ferone 2009 Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Acta Diabetol 46 85 95 19322513 10.1007/s00592-009-0112-9 1:CAS:528: DC%2BD1MXlsFKks78%3D
44. S Otabe H Nakayama T Fukutani X Yuan N Wada T Hashinaga A Mitsui T Kato C Inada Y Tajiri K Yamada 2010 Excessive maternal transmission of diabetes in Japanese families with young-onset type 2 diabetes and insulin secretion defect according to clinical features Acta Diabetol 47 Suppl 1 133 138 19787289 10.1007/s00592-009-0152-1 1:CAS:528:DC%2BC3cXhsFOiu7%2FE
45. G Sesti MA Marini M Cardellini A Sciacqua S Frontoni F Andreozzi C Irace D Lauro A Gnasso M Federici F Perticone R Lauro 2004 The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes Diabetes Care 27 1394 1398 15161794 10.2337/diacare.27.6.1394 1:CAS:528:DC%2BD2cXlt1ylur0%3D (Pubitemid 38679989)